Cibus Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.08

-0.16 (-7.14%)

As of Feb 8, 2:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +1,361.5% upside

Low Target $22.94

Average Target $30.40

High Target $39.68

Current Price $2.08

Current
$2.08

Target
$30.40

$22.94 $30.40 avg $39.68

Scenario Analysis

Bear Case

$22.94

1,002.9%

Low target

Base Case

$30.40

+1,361.5%

Avg target

Bull Case

$39.68

+1,807.7%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$38.58

-94.6% from high

52-Week Low

$16.23

+-87.2% from low

Target vs 52W High

$30.40

-21.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%